Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Yael L. Maxwell

July 03, 2024

News Daily News

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

L.A. McKeown

April 22, 2024

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP-Lowering KARDIA-1

News Conference News AHA 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

Caitlin E. Cox

November 11, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

News Daily News

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Yael L. Maxwell

February 28, 2019

News Daily News

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Michael O'Riordan

July 25, 2017

News Daily News

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Michael O'Riordan

June 28, 2016

News Daily News

Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs

Todd Neale

January 20, 2016

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

Advertisement

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content